More good news about neuropsychological late effects in long-term survivors of acute lymphoblastic leukemia.
Waber
Deborah P
DP
Department of Psychiatry, The Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003072:Cognition Disorders / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology; D003131:Combined Modality Therapy / Q000639:trends; D016371:Cranial Irradiation / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D007859:Learning Disabilities / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology; D009483:Neuropsychological Tests; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy / Q000523:psychology / Q000532:radiotherapy; D011788:Quality of Life; D017741:Survivors / Q000523:psychology*; D016896:Treatment Outcome